# Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors

> **NCT00081848** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 12 (actual)

## Conditions studied

- Liver Neoplasms

## Interventions

- **DRUG:** rV-CEA(6D)/TRICOM-rF-CEA(6D)/TRICOM
- **DRUG:** rF-CEA(6D)/TRICOM
- **DRUG:** Recombinant Fowlpox-GM-CSF
- **DRUG:** Celecoxib

## Key facts

- **NCT ID:** NCT00081848
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04-20
- **Primary completion:** 2007-08-23
- **Final completion:** 2007-08-23
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00081848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00081848, "Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00081848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*